Interestingly, in the study conducted by Campaner et al.31, microarray analysis revealed that treatment with KPT-6566 in breast cancer cells resulted in the upregulation of NRF2-mediated oxidative stress elements31. Here, NFE2L2 is linked to breast cancer.